|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1999-12-21
|
|
pubmed:abstractText |
Campath 1H is a depleting, humanized anti-CD52 monoclonal antibody that has now been used in 31 renal allograft recipients. The results have been very encouraging and are presented herein.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Creatinine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/alemtuzumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1613-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10589966-Adult,
pubmed-meshheading:10589966-Aged,
pubmed-meshheading:10589966-Antibodies, Monoclonal,
pubmed-meshheading:10589966-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:10589966-Antibodies, Neoplasm,
pubmed-meshheading:10589966-Creatinine,
pubmed-meshheading:10589966-Cyclosporine,
pubmed-meshheading:10589966-Dose-Response Relationship, Drug,
pubmed-meshheading:10589966-Female,
pubmed-meshheading:10589966-Follow-Up Studies,
pubmed-meshheading:10589966-Humans,
pubmed-meshheading:10589966-Immunosuppressive Agents,
pubmed-meshheading:10589966-Kidney Transplantation,
pubmed-meshheading:10589966-Lymphocyte Count,
pubmed-meshheading:10589966-Male,
pubmed-meshheading:10589966-Middle Aged,
pubmed-meshheading:10589966-Time Factors,
pubmed-meshheading:10589966-Tissue Donors,
pubmed-meshheading:10589966-Transplantation, Homologous,
pubmed-meshheading:10589966-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
|
|
pubmed:affiliation |
Addenbrooke's Hospital, Cambridge University Clinical School, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
